基于多维度临床指标构建支原体肺炎肺实变患儿电子支气管镜治疗效果预测模型及临床验证

张丽, 刘丽敏, 冯彦敏, 王云茹

湖南师范大学学报医学版 ›› 2026, Vol. 23 ›› Issue (3) : 96-102.

PDF(3363 KB)
PDF(3363 KB)
湖南师范大学学报医学版 ›› 2026, Vol. 23 ›› Issue (3) : 96-102.
临床医学

基于多维度临床指标构建支原体肺炎肺实变患儿电子支气管镜治疗效果预测模型及临床验证

  • 张丽, 刘丽敏, 冯彦敏, 王云茹
作者信息 +

Prediction Model Construction and Clinical Validation of Electronic Bronchoscopy Treatment in Children with Mycoplasma Pneumonia and Pulmonary Consolidation Based on Multidimensional Clinical Indicators

  • ZHANG Li, LIU Limin, FENG Yanmin, WANG Yunru
Author information +
文章历史 +

摘要

目的 基于多维度临床指标构建支原体肺炎肺实变患儿电子支气管镜治疗效果预测模型,并对该模型的效能进行临床验证。方法 选取2022年1月—2024年12月期间,本院收治的168例经电子支气管镜治疗的支原体肺炎肺实变患儿为研究样本,根据治疗效果将患儿分为125例的有效组和43例的无效组,对两组患儿的多模态数据,包括医学影像、临床检验指标、症状体征等进行单因素分析,采用Logistic回归分析影响支原体肺炎肺实变患儿电子支气管镜治疗效果的危险因素,采用受试者工作特征(receiver operating characteristic,ROC)曲线分析危险因素及列线图预测对支原体肺炎肺实变患儿电子支气管镜治疗效果的预测效能。结果 无效组的肺实变范围、肺不张情况、中性粒细胞和淋巴细胞比值(neutrophil to lymphocyte ratio,NLR)、C反应蛋白(C-reactive protein,CRP)、血清支原体抗体滴度和有效组相比,差异有统计学意义(P<0.05)。大范围肺实变、合并肺不张、高NLR、高CRP、血清支原体抗体滴度为1∶320及以上都是影响支原体肺炎肺实变患儿电子支气管镜治疗效果不良的危险因素(P<0.05)。肺实变范围、肺不张、NLR、CRP、血清支原体抗体滴度及五项指标联合预测的曲线下面积(area under the curve,AUC)分别为0.729、0.637、0.898、0.754、0.709、0.972,其中联合预测的AUC最高,表明联合多指标预测的效能最佳,同时联合预测的灵敏度和特异度最高,分别为95.3%和90.4%。结论 基于医学影像(如肺实变范围、肺不张情况)、临床检验指标(NLR、CRP、血清支原体抗体滴度)等多维度临床指标构建预测模型,经临床验证,这些指标联合预测对支原体肺炎肺实变患儿电子支气管镜治疗效果的评估效能显著,且具备良好的灵敏度和特异度。

Abstract

Objective To construct a prediction model for the therapeutic effect of electronic bronchoscopy in children with Mycoplasma pneumoniae pneumonia and pulmonary consolidation based on multidimensional clinical indicators, and to validate the model's efficacy clinically. Methods A total of 168 pediatric patients with Mycoplasma pneumoniae pneumonia and pulmonary consolidation who underwent electronic bronchoscopy treatment at our hospital from January 2022 to December 2024 were selected as the study subjects. According to the treatment outcome, they were divided into an effective group (125 cases) and an ineffective group (43 cases). Univariate analysis was conducted on multimodal data from the two groups, including medical imaging, clinical laboratory indicators, symptoms, and signs. Binary logistic regression was used to analyze the risk factors affecting the efficacy of electronic bronchoscopy treatment in children with Mycoplasma pneumoniae pneumonia and pulmonary consolidation. The predictive performance of the identified risk factors and a nomogram for the treatment outcome was evaluated using the receiver operating characteristic (ROC) curve. Results Significant differences were observed between the ineffective and effective groups in the extent of pulmonary consolidation, presence of atelectasis, NLR, CRP, and serum mycoplasma antibody titers (P<0.05). Large consolidation area, presence of atelectasis, elevated NLR, elevated CRP, and antibody titers ≥1∶320 were risk factors for poor treatment outcomes (P<0.05). The AUC values for the extent of consolidation, atelectasis, NLR, CRP, antibody titers, and the combined prediction were 0.729, 0.637, 0.898, 0.754, 0.709, and 0.972, respectively. The combined prediction achieved the highest AUC, along with the highest sensitivity (95.3%) and specificity (90.4%). Conclusion A prediction model based on multidimensional clinical indicators—including imaging findings (extent of consolidation, atelectasis) and laboratory markers (NLR, CRP, serum antibody titers) —demonstrates strong efficacy in predicting the therapeutic outcomes of electronic bronchoscopy in children with Mycoplasma pneumoniae pneumonia and pulmonary consolidation, with good sensitivity and specificity.

关键词

多维度临床指标 / 支原体肺炎 / 肺实变 / 电子支气管镜 / 治疗效果

Key words

multidimensional clinical indicators / Mycoplasma pneumoniae pneumonia / lung consolidation / electronic bronchoscopy / treatment effect

引用本文

导出引用
张丽, 刘丽敏, 冯彦敏, 王云茹. 基于多维度临床指标构建支原体肺炎肺实变患儿电子支气管镜治疗效果预测模型及临床验证[J]. 湖南师范大学学报医学版. 2026, 23(3): 96-102
ZHANG Li, LIU Limin, FENG Yanmin, WANG Yunru. Prediction Model Construction and Clinical Validation of Electronic Bronchoscopy Treatment in Children with Mycoplasma Pneumonia and Pulmonary Consolidation Based on Multidimensional Clinical Indicators[J]. Journal of Hunan Normal University(Medical Science). 2026, 23(3): 96-102
中图分类号: R725.6   

参考文献

[1] GAO L, SUN Y.Laboratory diagnosis and treatment of Mycoplasma pneumoniae infection in children: a review[J]. Ann Med, 2024, 56(1): 2386636.
[2] SHEN X, JIN Z, CHEN X, et al.Single-cell transcriptome atlas revealed bronchoalveolar immune features related to disease severity in pediatric Mycoplasma pneumoniae pneumonia[J]. MedComm, 2024, 5(10): e748.
[3] ROWLANDS RS, MEYER SAUTEUR PM, BEETON ML, et al.Mycoplasma pneumoniae: not a typical respiratory pathogen[J]. J Med Microbiol, 2024, 73(10): 001910.
[4] ZHUO LY, HAO JW, SONG ZJ, et al.Predicting the severity of mycoplasma pneumoniae pneumonia in pediatric and adult patients: a multicenter study[J]. Sci Rep, 2024, 14(1): 22978.
[5] 吕田, 赵德育. 儿童肺炎支原体肺炎影像学表现与预后关系研究进展[J]. 传染病信息, 2025, 38(5): 506-511.
[6] 黄铖铖, 万小梅, 吴李龙, 等. 学龄前儿童肺炎支原体感染致肺实变/肺不张的危险因素分析[J]. 皖南医学院学报, 2024, 43(6): 539-542.
[7] 中华医学会儿科学分会呼吸学组, 国家呼吸系统疾病临床医学研究中心, 中华儿科杂志编辑委员会. 儿童肺炎支原体肺炎诊断与治疗循证指南 (2023)[J]. 中华儿科杂志, 2024, 62(12): 1137-1144.
[8] 代尧, 黎佳慧, 徐秀红, 等. 基于肺炎支原体DNA和外周血炎症指标构建儿童肺炎支原体肺炎预后评估模型[J]. 检验医学, 2024, 39(6): 568-572.
[9] ZHANG X, SUN R, JIA W, et al.Clinical characteristics of lung consolidation with Mycoplasma pneumoniae pneumonia and risk factors for Mycoplasma pneumoniae necrotizing pneumonia in children[J]. Infect Dis Ther, 2024, 13(2): 329-343.
[10] LI S, ZHANG QL, GUO RJ, et al.Quantitative evaluation and significance of ultrasound in bronchoalveolar lavage for lung consolidation in children with severe mycoplasma pneumonia[J]. Transl Pediatr, 2021, 10(9): 2325-2334.
[11] 左蕾, 黄毅, 薛莲, 等. 肺部超声监测在儿童肺炎支原体肺炎临床诊疗中的应用价值[J]. 中华超声影像学杂志, 2025, 34(3): 203-209.
[12] 张雪梅, 陈佩灵, 钟丽萍. 血清IL-25, CXCR4水平与肺炎支原体肺炎伴肺不张患儿呼吸力学指标及预后的关系[J]. 医学综述, 2023, 29(24): 5853-5858.
[13] LI S, ZHOU J, HE J, et al.Clinical profiles of mycoplasma pneumoniae pneumonia in children with different pleural effusion patterns: a retrospective study[J]. BMC Infect Dis, 2024, 24(1): 919.
[14] 唐青, 赵龙, 张雯, 等. 外周血NLR, PLR和MPVLR水平对儿童难治性肺炎支原体肺炎的预测价值[J]. 国际呼吸杂志, 2024, 44(9): 1061-1066.
[15] HU M, SHEN X, LI M, et al.Efficacy of bronchoalveolar lavage in treating mycoplasma pneumonia and bacterial pneumonia with atelectasis in children[J]. Transl Pediatr, 2025, 14(3): 432-441.
[16] 李革, 余怡如, 陈放, 等. NLR, 25- (OH) D3, IL-6, PCT与重症肺炎支原体肺炎患儿免疫功能和预后不良的关系研究[J]. 现代生物医学进展, 2023, 23(3): 461-465.
[17] 佘吉佳, 陈传贵, 邸咪. WBC, CRP, SAA, PCT在儿童肺炎支原体肺炎中的临床运用价值[J]. 检验医学与临床, 2023, 20(1): 11-14.
[18] LIANG M, ZHANG H, LI Y, et al.A prediction model for bronchoalveolar lavage in children with Mycoplasma pneumoniae pneumonia and consolidation[J]. Sci Rep, 2026, 16(1): 3152.
[19] 罗虎, 何雪莲. LDH, CRP, 中性杆状核粒细胞百分比在儿科支原体肺炎与细菌性肺炎鉴别诊断中的价值[J]. 标记免疫分析与临床, 2024, 31(2): 197-202.
[20] 张立霞, 朱峰, 李传景, 等. 重症肺炎支原体肺炎患儿CRP, LDH等实验室指标的预警价值及支气管镜下特点[J]. 中华全科医学, 2024, 22(7): 1098-1101.
[21] 辉琪, 崔玥, 张雯婷, 等. 血常规相关参数在儿童支原体肺炎中的表达及临床价值[J]. 临床血液学杂志, 2023, 36(12): 860-864.
[22] 柴彦艳, 邓芳, 许愿愿, 等. 重症肺炎支原体肺炎患儿临床特征与实验室指标及预后的关系[J]. 中华医院感染学杂志, 2025, 35(20): 3124-3127.
[23] 刘玉雄, 蔡强, 申敏, 等. 肺炎支原体肺炎患儿28天预后的影响因素[J]. 中华医院感染学杂志, 2025, 35(16): 2481-2484.
[24] 郝晓飞, 王育民, 宋惠芳, 等. 重症肺炎支原体肺炎患儿血清IL-8, IL-2, CRP及PCT表达水平及意义[J]. 中南医学科学杂志, 2026, 54(1): 138-141.

基金

邢台市重点研发计划自筹项目“构建支原体肺炎伴肺实变患儿行EB治疗预测模型及其临床应用”(2024ZC199)

PDF(3363 KB)

Accesses

Citation

Detail

段落导航
相关文章

/

〈 〉